{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T13:23:04Z","timestamp":1767964984954,"version":"3.49.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T00:00:00Z","timestamp":1560902400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T00:00:00Z","timestamp":1560902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["F30 CA180607"],"award-info":[{"award-number":["F30 CA180607"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA218802"],"award-info":[{"award-number":["R01 CA218802"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R21 CA223394-01A1"],"award-info":[{"award-number":["R21 CA223394-01A1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA006927"],"award-info":[{"award-number":["P30 CA006927"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5795-x","type":"journal-article","created":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T11:17:03Z","timestamp":1560943023000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4022-0596","authenticated-orcid":false,"given":"Tim N.","family":"Beck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanis A.","family":"Boumber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charu","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianming","family":"Pei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Thrash-Bingham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Fittipaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramillya","family":"Vlasenkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandra","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Borghaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Cristofanilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranee","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilya","family":"Serebriiskii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Katherine","family":"Alpaugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,19]]},"reference":[{"issue":"1","key":"5795_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"7689","key":"5795_CR2","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446\u201354.","journal-title":"Nature"},{"key":"5795_CR3","volume-title":"SEER Cancer Statistics Review, 1975-2010, National Cancer Institute","year":"2013","unstructured":"Howlader N NA, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds): SEER Cancer Statistics Review, 1975-2010, National Cancer Institute. 2013."},{"issue":"12","key":"5795_CR4","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nrc.2017.106","volume":"17","author":"AF Gazdar","year":"2017","unstructured":"Gazdar AF, Bunn PA, Minna JD. Small-cell lung cancer: what we know, what we need to know and the path forward. Nat Rev Cancer. 2017;17(12):765.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"5795_CR5","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","volume":"168","author":"N McGranahan","year":"2017","unstructured":"McGranahan N, Swanton C. Clonal heterogeneity and tumor evolution: past, present, and the future. Cell. 2017;168(4):613\u201328.","journal-title":"Cell"},{"issue":"3","key":"5795_CR6","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.celrep.2016.06.043","volume":"16","author":"TN Beck","year":"2016","unstructured":"Beck TN, Korobeynikov VA, Kudinov AE, Georgopoulos R, Solanki NR, Andrews-Hoke M, Kistner TM, Pepin D, Donahoe PK, Nicolas E, et al. Anti-Mullerian hormone signaling regulates epithelial plasticity and Chemoresistance in lung Cancer. Cell Rep. 2016;16(3):657\u201371.","journal-title":"Cell Rep"},{"key":"5795_CR7","unstructured":"Belyaeva MIV, N.I.; Vinter, V. G.; Balaban, N.P.: On secretion of nucleic acids by cancer cells. Proceedings of the IX International Cancer Congress, Tokyo, Japan 1966."},{"issue":"8","key":"5795_CR8","first-page":"1961","volume":"5","author":"MS Kopreski","year":"1999","unstructured":"Kopreski MS, Benko FA, Kwak LW, Gocke CD. Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin Cancer Res. 1999;5(8):1961\u20135.","journal-title":"Clin Cancer Res"},{"key":"5795_CR9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.lungcan.2017.08.008","volume":"112","author":"C Aggarwal","year":"2017","unstructured":"Aggarwal C, Wang X, Ranganathan A, Torigian D, Troxel A, Evans T, Cohen RB, Vaidya B, Rao C, Connelly M, et al. Circulating tumor cells as a predictive biomarker in patients with small cell lung cancer undergoing chemotherapy. Lung Cancer. 2017;112:118\u201325.","journal-title":"Lung Cancer"},{"issue":"2","key":"5795_CR10","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/JTO.0b013e31823c5c16","volume":"7","author":"MG Krebs","year":"2012","unstructured":"Krebs MG, Hou J-M, Sloane R, Lancashire L, Priest L, Nonaka D, Ward TH, Backen A, Clack G, Hughes A, et al. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches. J Thorac Oncol. 2012;7(2):306\u201315.","journal-title":"J Thorac Oncol"},{"issue":"4","key":"5795_CR11","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","volume":"127","author":"GP Gupta","year":"2006","unstructured":"Gupta GP, Massague J. Cancer metastasis: building a framework. Cell. 2006;127(4):679\u201395.","journal-title":"Cell"},{"issue":"2","key":"5795_CR12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.critrevonc.2014.10.001","volume":"93","author":"A Tognela","year":"2015","unstructured":"Tognela A, Spring KJ, Becker T, Caixeiro NJ, Bray VJ, Yip PY, Chua W, Lim SH, de Souza P. Predictive and prognostic value of circulating tumor cell detection in lung cancer: a clinician's perspective. Crit Rev Oncol Hematol. 2015;93(2):90\u2013102.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"5795_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3816\/CCC.2006.n.029","volume":"6","author":"SJ Cohen","year":"2006","unstructured":"Cohen SJ, Alpaugh RK, Gross S, O'Hara SM, Smirnov DA, Terstappen LWMM, Allard WJ, Bilbee M, Cheng JD, Hoffman JP, et al. Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer. Clin Colorectal Cancer. 2006;6(2):125\u201332.","journal-title":"Clin Colorectal Cancer"},{"issue":"19","key":"5795_CR14","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1200\/JCO.2007.15.8923","volume":"26","author":"SJ Cohen","year":"2008","unstructured":"Cohen SJ, Punt CJA, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J, Morse M, Mitchell E, Miller MC, et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol. 2008;26(19):3213\u201321.","journal-title":"J Clin Oncol"},{"issue":"8","key":"5795_CR15","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1056\/NEJMoa040766","volume":"351","author":"M Cristofanilli","year":"2004","unstructured":"Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LWMM, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004;351(8):781\u201391.","journal-title":"N Engl J Med"},{"issue":"7","key":"5795_CR16","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1200\/JCO.2005.08.140","volume":"23","author":"M Cristofanilli","year":"2005","unstructured":"Cristofanilli M, Hayes DF, Budd GT, Ellis MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC, et al. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol. 2005;23(7):1420\u201330.","journal-title":"J Clin Oncol"},{"issue":"11","key":"5795_CR17","doi-asserted-by":"publisher","first-page":"e78070","DOI":"10.1371\/journal.pone.0078070","volume":"8","author":"J Wang","year":"2013","unstructured":"Wang J, Wang K, Xu J, Huang J, Zhang T. Prognostic significance of circulating tumor cells in non-small-cell lung cancer patients: a meta-analysis. PLoS One. 2013;8(11):e78070.","journal-title":"PLoS One"},{"issue":"1","key":"5795_CR18","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1038\/s41598-017-05154-x","volume":"7","author":"Y Li","year":"2017","unstructured":"Li Y, Cheng X, Chen Z, Liu Y, Liu Z, Xu S. Circulating tumor cells in peripheral and pulmonary venous blood predict poor long-term survival in resected non-small cell lung cancer patients. Sci Rep. 2017;7(1):4971.","journal-title":"Sci Rep"},{"issue":"9","key":"5795_CR19","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1158\/0008-5472.CAN-16-3072","volume":"77","author":"E Pailler","year":"2017","unstructured":"Pailler E, Oulhen M, Borget I, Remon J, Ross K, Auger N, Billiot F, Ngo Camus M, Commo F, Lindsay CR, et al. Circulating tumor cells with aberrant ALK copy number predict progression-free survival during Crizotinib treatment in ALK-rearranged non-small cell lung Cancer patients. Cancer Res. 2017;77(9):2222\u201330.","journal-title":"Cancer Res"},{"issue":"8","key":"5795_CR20","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1073\/pnas.95.8.4589","volume":"95","author":"E Racila","year":"1998","unstructured":"Racila E, Euhus D, Weiss AJ, Rao C, McConnell J, Terstappen LW, Uhr JW. Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci U S A. 1998;95(8):4589\u201394.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"5795_CR21","doi-asserted-by":"publisher","first-page":"6897","DOI":"10.1158\/1078-0432.CCR-04-0378","volume":"10","author":"WJ Allard","year":"2004","unstructured":"Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AGJ, Uhr JW, Terstappen LWMM. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res. 2004;10(20):6897\u2013904.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"5795_CR22","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1158\/1078-0432.CCR-06-1695","volume":"13","author":"S Riethdorf","year":"2007","unstructured":"Riethdorf S, Fritsche H, Muller V, Rau T, Schindlbeck C, Rack B, Janni W, Coith C, Beck K, Janicke F, et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res. 2007;13(3):920\u20138.","journal-title":"Clin Cancer Res"},{"key":"5795_CR23","doi-asserted-by":"publisher","first-page":"12270","DOI":"10.1038\/srep12270","volume":"5","author":"S de Wit","year":"2015","unstructured":"de Wit S, van Dalum G, Lenferink AT, Tibbe AG, Hiltermann TJ, Groen HJ, van Rijn CJ, Terstappen LW. The detection of EpCAM(+) and EpCAM(\u2212) circulating tumor cells. Sci Rep. 2015;5:12270.","journal-title":"Sci Rep"},{"key":"5795_CR24","doi-asserted-by":"publisher","first-page":"28010","DOI":"10.1038\/srep28010","volume":"6","author":"A Hanssen","year":"2016","unstructured":"Hanssen A, Wagner J, Gorges TM, Taenzer A, Uzunoglu FG, Driemel C, Stoecklein NH, Knoefel WT, Angenendt S, Hauch S, et al. Characterization of different CTC subpopulations in non-small cell lung cancer. Sci Rep. 2016;6:28010.","journal-title":"Sci Rep"},{"issue":"50","key":"5795_CR25","doi-asserted-by":"publisher","first-page":"83424","DOI":"10.18632\/oncotarget.13117","volume":"7","author":"WS Brown","year":"2016","unstructured":"Brown WS, Akhand SS, Wendt MK. FGFR signaling maintains a drug persistent cell population following epithelial-mesenchymal transition. Oncotarget. 2016;7(50):83424\u201336.","journal-title":"Oncotarget"},{"issue":"5","key":"5795_CR26","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","volume":"20","author":"M Labelle","year":"2011","unstructured":"Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell. 2011;20(5):576\u201390.","journal-title":"Cancer Cell"},{"issue":"7","key":"5795_CR27","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/j.celrep.2016.10.031","volume":"17","author":"F Pucci","year":"2016","unstructured":"Pucci F, Rickelt S, Newton AP, Garris C, Nunes E, Evavold C, Pfirschke C, Engblom C, Mino-Kenudson M, Hynes RO, et al. PF4 promotes platelet production and lung Cancer growth. Cell Rep. 2016;17(7):1764\u201372.","journal-title":"Cell Rep"},{"issue":"30","key":"5795_CR28","doi-asserted-by":"publisher","first-page":"E3053","DOI":"10.1073\/pnas.1411082111","volume":"111","author":"M Labelle","year":"2014","unstructured":"Labelle M, Begum S, Hynes RO. Platelets guide the formation of early metastatic niches. Proc Natl Acad Sci U S A. 2014;111(30):E3053\u201361.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"5795_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrc3004","volume":"11","author":"LJ Gay","year":"2011","unstructured":"Gay LJ, Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat Rev Cancer. 2011;11(2):123\u201334.","journal-title":"Nat Rev Cancer"},{"key":"5795_CR30","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/978-1-4939-2990-0_18","volume":"1347","author":"F Coumans","year":"2015","unstructured":"Coumans F, Terstappen L. Detection and characterization of circulating tumor cells by the CellSearch approach. Methods Mol Biol. 2015;1347:263\u201378.","journal-title":"Methods Mol Biol"},{"issue":"12","key":"5795_CR31","doi-asserted-by":"publisher","first-page":"e82241","DOI":"10.1371\/journal.pone.0082241","volume":"8","author":"B Gyorffy","year":"2013","unstructured":"Gyorffy B, Surowiak P, Budczies J, Lanczky A. Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PLoS One. 2013;8(12):e82241.","journal-title":"PLoS One"},{"issue":"D1","key":"5795_CR32","doi-asserted-by":"publisher","first-page":"D362","DOI":"10.1093\/nar\/gkw937","volume":"45","author":"D Szklarczyk","year":"2017","unstructured":"Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 2017;45(D1):D362\u20138.","journal-title":"Nucleic Acids Res"},{"key":"5795_CR33","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/978-1-62703-721-1_11","volume":"1101","author":"H Liu","year":"2014","unstructured":"Liu H, Beck TN, Golemis EA, Serebriiskii IG. Integrating in silico resources to map a signaling network. Methods Mol Biol. 2014;1101:197\u2013245.","journal-title":"Methods Mol Biol"},{"issue":"D1","key":"5795_CR34","doi-asserted-by":"publisher","first-page":"D649","DOI":"10.1093\/nar\/gkx1132","volume":"46","author":"A Fabregat","year":"2018","unstructured":"Fabregat A, Jupe S, Matthews L, Sidiropoulos K, Gillespie M, Garapati P, Haw R, Jassal B, Korninger F, May B, et al. The Reactome pathway knowledgebase. Nucleic Acids Res. 2018;46(D1):D649\u201355.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"5795_CR35","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nbt.4017","volume":"36","author":"C Kumar-Sinha","year":"2018","unstructured":"Kumar-Sinha C, Chinnaiyan AM. Precision oncology in the age of integrative genomics. Nat Biotechnol. 2018;36(1):46\u201360.","journal-title":"Nat Biotechnol"},{"issue":"10","key":"5795_CR36","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.molmed.2017.08.003","volume":"23","author":"D Senft","year":"2017","unstructured":"Senft D, Leiserson MDM, Ruppin E, Ronai ZA. Precision oncology: the road ahead. Trends Mol Med. 2017;23(10):874\u201398.","journal-title":"Trends Mol Med"},{"issue":"1","key":"5795_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/jcm6010003","volume":"6","author":"Nithya Krishnamurthy","year":"2017","unstructured":"Krishnamurthy N, Spencer E, Torkamani A, Nicholson L. Liquid biopsies for Cancer: coming to a patient near you. J Clin Med. 2017;6(1):1\u20138.","journal-title":"Journal of Clinical Medicine"},{"key":"5795_CR38","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.12688\/f1000research.11313.1","volume":"6","author":"LanLan Zhou","year":"2017","unstructured":"Zhou L, Dicker DT, Matthew E, El-Deiry WS, Alpaugh RK. Circulating tumor cells: silent predictors of metastasis. F1000Res. 2017;6:1\u20138.","journal-title":"F1000Research"},{"issue":"2","key":"5795_CR39","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/cyto.a.22613","volume":"87","author":"DL Adams","year":"2015","unstructured":"Adams DL, Stefansson S, Haudenschild C, Martin SS, Charpentier M, Chumsri S, Cristofanilli M, Tang C-M, Alpaugh RK. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch() CTC test. Cytometry A. 2015;87(2):137\u201344.","journal-title":"Cytometry A"},{"issue":"1","key":"5795_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto MA, Huang RY, Jackson RA, Thiery JP. Emt: 2016. Cell. 2016;166(1):21\u201345.","journal-title":"Cell"},{"issue":"2","key":"5795_CR41","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10456-012-9259-z","volume":"15","author":"JE Peterson","year":"2012","unstructured":"Peterson JE, Zurakowski D, Italiano JE Jr, Michel LV, Connors S, Oenick M, D'Amato RJ, Klement GL, Folkman J. VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients. Angiogenesis. 2012;15(2):265\u201373.","journal-title":"Angiogenesis"},{"issue":"17","key":"5795_CR42","doi-asserted-by":"publisher","first-page":"27725","DOI":"10.18632\/oncotarget.9486","volume":"8","author":"J Jian","year":"2017","unstructured":"Jian J, Pang Y, Yan HH, Min Y, Achyut BR, Hollander MC, Lin PC, Liang X, Yang L. Platelet factor 4 is produced by subsets of myeloid cells in premetastatic lung and inhibits tumor metastasis. Oncotarget. 2017;8(17):27725\u201339.","journal-title":"Oncotarget"},{"issue":"1","key":"5795_CR43","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1189\/jlb.0105024","volume":"78","author":"A Schaffner","year":"2005","unstructured":"Schaffner A, Rhyn P, Schoedon G, Schaer DJ. Regulated expression of platelet factor 4 in human monocytes--role of PARs as a quantitatively important monocyte activation pathway. J Leukoc Biol. 2005;78(1):202\u20139.","journal-title":"J Leukoc Biol"},{"key":"5795_CR44","doi-asserted-by":"publisher","first-page":"292376","DOI":"10.1155\/2014\/292376","volume":"2014","author":"D Aldinucci","year":"2014","unstructured":"Aldinucci D, Colombatti A. The inflammatory chemokine CCL5 and cancer progression. Mediat Inflamm. 2014;2014:292376.","journal-title":"Mediat Inflamm"},{"key":"5795_CR45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1155\/2013\/453561","volume":"2013","author":"A Smeets","year":"2013","unstructured":"Smeets A, Brouwers B, Hatse S, Laenen A, Paridaens R, Floris G, Wildiers H, Christiaens M-R. Circulating CCL5 Levels in Patients with Breast Cancer: Is There a Correlation with Lymph Node Metastasis? ISRN Immunology. 2013;2013:5.","journal-title":"ISRN Immunology"},{"issue":"2","key":"5795_CR46","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/14728222.2017.1267142","volume":"21","author":"MR Wilson","year":"2017","unstructured":"Wilson MR, Zoubeidi A. Clusterin as a therapeutic target. Expert Opin Ther Targets. 2017;21(2):201\u201313.","journal-title":"Expert Opin Ther Targets"},{"issue":"2","key":"5795_CR47","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","volume":"134","author":"J Massague","year":"2008","unstructured":"Massague J. TGFbeta in Cancer. Cell. 2008;134(2):215\u201330.","journal-title":"Cell"},{"issue":"7693","key":"5795_CR48","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, Kadel Iii EE, Koeppen H, Astarita JL, Cubas R, et al. TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018;554(7693):544\u20138.","journal-title":"Nature"},{"issue":"25","key":"5795_CR49","doi-asserted-by":"publisher","first-page":"6955","DOI":"10.1073\/pnas.1513616113","volume":"113","author":"AE Kudinov","year":"2016","unstructured":"Kudinov AE, Deneka A, Nikonova AS, Beck TN, Ahn YH, Liu X, Martinez CF, Schultz FA, Reynolds S, Yang DH, et al. Musashi-2 (MSI2) supports TGF-beta signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis. Proc Natl Acad Sci U S A. 2016;113(25):6955\u201360.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"5795_CR50","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1152\/physiolgenomics.00062.2014","volume":"46","author":"TN Beck","year":"2014","unstructured":"Beck TN, Chikwem AJ, Solanki NR, Golemis EA. Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancer. Physiol Genomics. 2014;46(19):699\u2013724.","journal-title":"Physiol Genomics"},{"issue":"18","key":"5795_CR51","doi-asserted-by":"publisher","first-page":"5611","DOI":"10.1158\/1078-0432.CCR-16-3272","volume":"23","author":"Q Hu","year":"2017","unstructured":"Hu Q, Hisamatsu T, Haemmerle M, Cho MS, Pradeep S, Rupaimoole R, Rodriguez-Aguayo C, Lopez-Berestein G, Wong STC, Sood AK, et al. Role of platelet-derived Tgfbeta1 in the progression of ovarian Cancer. Clin Cancer Res. 2017;23(18):5611\u201321.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"5795_CR52","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1182\/blood-2004-06-2475","volume":"105","author":"P von Hundelshausen","year":"2005","unstructured":"von Hundelshausen P, Koenen RR, Sack M, Mause SF, Adriaens W, Proudfoot AE, Hackeng TM, Weber C. Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood. 2005;105(3):924\u201330.","journal-title":"Blood"},{"issue":"8","key":"5795_CR53","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.4049\/jimmunol.150.8.3448","volume":"150","author":"HE Broxmeyer","year":"1993","unstructured":"Broxmeyer HE, Sherry B, Cooper S, Lu L, Maze R, Beckmann MP, Cerami A, Ralph P. Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression. J Immunol. 1993;150(8 Pt 1):3448\u201358.","journal-title":"J Immunol"},{"issue":"18","key":"5795_CR54","doi-asserted-by":"publisher","first-page":"4437","DOI":"10.1158\/1078-0432.CCR-18-0143","volume":"24","author":"Yuebi Hu","year":"2018","unstructured":"Hu Y, Ulrich BC, Supplee J, Kuang Y, Lizotte PH, Feeney NB, Guibert NM, Awad MM, Wong KK, Janne PA, et al. False-Positive Plasma Genotyping Due to Clonal Hematopoiesis. Clin Cancer Res. 2018;24(18);4437\u201343.","journal-title":"Clinical Cancer Research"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5795-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5795-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5795-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T15:37:59Z","timestamp":1694965079000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5795-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,19]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5795"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5795-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,19]]},"assertion":[{"value":"11 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol for this study was approved by the Fox Chase Cancer Center (FCCC) Institutional Review Board (IRB), study number 10\u2013043. Nanostring mRNA expression analysis was additionally covered by the FCCC IRB, study number 18\u20134002. Informed consent was obtained from patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Y.B. has served on advisory boards of Astra Zeneca, AbbVie and Caris Life Sciences. YB. Is also an Editorial Board member for <i>BMC Cancer<\/i>. C.A. has served on advisory boards of Genentech and Celgene. R. M. has served as a consultant for Genentech and on advisory board of Bristol-Meyers Squibb. H. B. has received research support for clinical trials from Millennium, Merck\/Celgene, BMS\/Lilly, has served on advisory board or as a consultant for BMS, Lilly, Genentech, Celgene, Pfizer, Merck, EMD-Serono, Boehringer Ingelheim, Astra Zeneca, Novartis, Genmab, Regeneron, BioNTech, Cantargia AB, Amgen, Abbvie, Axiom, PharmaMar, and on data and safety monitoring board for the University of Pennsylvania, CAR T Program. M.C. has served on advisory boards of Vortex, Dompe, and received research support from Pfizer and honoraria from Pfizer. The authors have no other conflicts to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"603"}}